How many FDA actions does Argus HQ track for Stryker Communications?

3 total: 0 warning letters, 3 recalls, 0 approval records, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for Stryker Communications?

April 8, 2026. Argus HQ ingests new FDA enforcement records daily.

Has Stryker Communications had product recalls?

Yes, 3 recalls on file. See the full history below for each one.

Is this FDA enforcement data for Stryker Communications official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

Stryker Communications — FDA Enforcement History

FDA action counts

Total FDA actions	3
Warning letters	0
Recalls	3
Approval records	0
Form 483 inspection citations	0
Most recent action	April 8, 2026

Key takeaway: Argus HQ has recorded 3 FDA events for Stryker Communications: 0 warning letters, 3 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2024-04-17 to 2026-04-08. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Enforcement history

On 2026-04-08, Argus HQ recorded an FDA recall for Stryker Communications, rated "high" severity in Argus HQ's classification: Stryker Communications — Class II recall: Stryker CHROMOPHARE Softlit Ring Surgical Light System REF: CH00000001. On 2025-10-01, Argus HQ recorded an FDA recall for Stryker Communications, rated "high" severity in Argus HQ's classification: Stryker Communications — Class II recall: Chromophare Surgical Light System, REF: CH00000001; SLX to Oculan NFC Upgrade Ki…. On 2024-04-17, Argus HQ recorded an FDA recall for Stryker Communications, rated "high" severity in Argus HQ's classification: Stryker Communications — Class II recall: Chromophare Surgical Light System , REF CH00000001. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Stryker Communications has 3 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Frequently asked questions

How many FDA actions does Argus HQ track for Stryker Communications?: 3 total: 0 warning letters, 3 recalls, 0 approval records, and 0 Form 483 inspection citations.
What is the most recent FDA action on file for Stryker Communications?: April 8, 2026. Argus HQ ingests new FDA enforcement records daily.
Has Stryker Communications had product recalls?: Yes, 3 recalls on file. See the full history below for each one.
Is this FDA enforcement data for Stryker Communications official?: Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Verified from FDA.gov · Last updated: Apr 8, 2026

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Stryker Communications — FDA Enforcement History. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/stryker-communications

MLA

"Stryker Communications — FDA Enforcement History." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/stryker-communications.

Chicago

Argus HQ Research. "Stryker Communications — FDA Enforcement History." Digital Empire Holdings LLC. Accessed July 17, 2026. https://argushq.ai/company/stryker-communications.

BibTeX

@misc{argushq_argushq_ai_company_stryker_communications_2026,
  title = {Stryker Communications — FDA Enforcement History},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/company/stryker-communications},
  note = {Accessed: July 17, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗